User profiles for Joanna Luczkowiak
Joanna LuczkowiakHospital 12 de Octubre Madrid Verified email at correo.h12o.es Cited by 1380 |
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
M Thépaut, J Luczkowiak, C Vivès, N Labiod… - PLoS …, 2021 - journals.plos.org
The efficient spread of SARS-CoV-2 resulted in a unique pandemic in modern history.
Despite early identification of ACE2 as the receptor for viral spike protein, much remains to be …
Despite early identification of ACE2 as the receptor for viral spike protein, much remains to be …
Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection
The use of multivalent carbohydrate compounds to block cell-surface lectin receptors is a
promising strategy to inhibit the entry of pathogens into cells and could lead to the discovery of …
promising strategy to inhibit the entry of pathogens into cells and could lead to the discovery of …
Glycofullerenes inhibit viral infection
J Luczkowiak, A Munoz, M Sanchez-Navarro… - …, 2013 - ACS Publications
Water-soluble glycofullerenes based on a hexakis-adduct of [60]fullerene with an octahedral
addition pattern are very attractive compounds providing a spherical presentation of …
addition pattern are very attractive compounds providing a spherical presentation of …
Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
…, M Sánchez-Navarro, J Luczkowiak… - Nature …, 2012 - nature.com
Ligand polyvalency is a powerful modulator of protein–receptor interactions. Host–pathogen
infection interactions are often mediated by glycan ligand–protein interactions, yet its …
infection interactions are often mediated by glycan ligand–protein interactions, yet its …
Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection
J Luczkowiak, S Sattin, I Sutkeviciute… - Bioconjugate …, 2011 - ACS Publications
The development of compounds with strong affinity for the receptor DC-SIGN is a topic of
remarkable interest due to the role that this lectin plays in several pathogen infection processes …
remarkable interest due to the role that this lectin plays in several pathogen infection processes …
[HTML][HTML] Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19
MD Folgueira, J Luczkowiak, F Lasala… - Clinical Microbiology …, 2021 - Elsevier
Objectives This study compares the infectivity of SARS-CoV-2 in respiratory samples from
patients with mild COVID-19 with those from hospitalized patients with severe bilateral …
patients with mild COVID-19 with those from hospitalized patients with severe bilateral …
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
…, L Sánchez-Paz, J Luczkowiak… - Frontiers in …, 2022 - frontiersin.org
Background SARS-CoV-2 vaccination has proven the most effective measure to control the
COVID-19 pandemic. Booster doses are being administered with limited knowledge on their …
COVID-19 pandemic. Booster doses are being administered with limited knowledge on their …
Nanocarbon-based glycoconjugates as multivalent inhibitors of Ebola virus infection
SWCNTs, MWCNTs, and SWCNHs have been employed as virus-mimicking nanocarbon
platforms for the multivalent presentation of carbohydrates in an artificial Ebola virus infection …
platforms for the multivalent presentation of carbohydrates in an artificial Ebola virus infection …
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from …
…, S Flores, PJ Sánchez-Cordón, J Luczkowiak… - Frontiers in …, 2022 - frontiersin.org
Current coronavirus disease-19 (COVID-19) vaccines are administered by the intramuscular
route, but this vaccine administration failed to prevent severe acute respiratory syndrome …
route, but this vaccine administration failed to prevent severe acute respiratory syndrome …
Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
…, PJ Sánchez-Cordón, M Guzmán, J Luczkowiak… - Npj Vaccines, 2022 - nature.com
Two doses of the MVA-CoV2-S vaccine candidate expressing the SARS-CoV-2 spike (S)
protein protected K18-hACE2 transgenic mice from a lethal dose of SARS-CoV-2. This …
protein protected K18-hACE2 transgenic mice from a lethal dose of SARS-CoV-2. This …